Two-Dimensional Speckle Tracking Echocardiography Detects Subclinical Left Ventricular Systolic Dysfunction among Adult Survivors of Childhood, Adolescent, and Young Adult Cancer

Abstract EN

Two-dimensional speckle tracking echocardiography (2DSTE) provides a sensitive measure of left ventricular (LV) systolic function and may aid in the diagnosis of cardiotoxicity.

2DSTE was performed in a cross-sectional study of 134 patients (mean age: 31.4±8.8 years; 55% male; mean time since diagnosis: 15.4±9.4 years) previously treated with anthracyclines (mean cumulative dose: 320±124 mg/m2), with (n=52) or without (n=82) mediastinal radiotherapy.

The prevalence of LV systolic dysfunction, defined as fractional shortening < 27%, LV ejection fraction (LVEF) < 55%, and global longitudinal strain (GLS) ≤ 16%, was 5.2%, 6.0%, and 23.1%, respectively.

Abnormal GLS was observed in 24 (18%) patients despite a normal LVEF.

Indices of LV systolic function were similar regardless of anthracycline dose.

However, GLS was worse (18.0 versus 19.0, p=0.003) and prevalence of abnormal GLS was higher (36.5% versus 14.6%, p=0.004) in patients treated with mediastinal radiotherapy.

Mediastinal radiotherapy was associated with reduced GLS (p=0.040) after adjusting for sex, age, and cumulative anthracycline dose.

In adult survivors of childhood, adolescent, and young adult cancer, 2DSTE frequently detects LV systolic dysfunction despite a normal LVEF and may be useful for the long-term cardiac surveillance of adult cancer survivors.